Targeting Chemokine (C-X-C motif) Receptor 3 in Thyroid Autoimmunity

Publisher： Bentham Science Publishers

E-ISSN： 2212-3334|8|2|95-101

ISSN： 1872-2148

Source： Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol.8, Iss.2, 2014-05, pp. : 95-101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optically Pure -Amino Acids Production by the “Hydantoinase Process”

By  

Recent Patents on Biotechnology, Vol. 2, Iss. 1, 2008-01 ,pp. : 35-46

Bentham Science Publishers

Access to resources Recommend Favorite

ErbB Antagonists Patenting: “Playing Chess with Cancer”

By  

Recent Patents on Biotechnology, Vol. 2, Iss. 3, 2008-01 ,pp. : 181-187

Bentham Science Publishers

Access to resources Recommend Favorite

Exploring the Role of “Brahmi” (Bocopa monnieri and Centella asiatica) in Brain Function and Therapy

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 5, Iss. 1, 2011-01 ,pp. : 33-49

Bentham Science Publishers

Access to resources Recommend Favorite

The “Humivent” Device for Rising Damp Treatment

By  

Recent Patents on Engineering, Vol. 5, Iss. 3, 2011-12 ,pp. : 233-240

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Chemokine Receptor-Targeted Depletion of Pathological Cells as A Therapeutic Strategy for Inflammatory, Allergic and Autoimmune Diseases

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 3, Iss. 3, 2009-11 ,pp. : 177-187

Bentham Science Publishers

Access to resources Recommend Favorite